catechin has been researched along with trichostatin a in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gopalakrishnan, A; Hebbar, V; Khor, TO; Kong, AN; Nair, S; Shen, G; Xu, C; Yu, S | 1 |
| Li, Y; Meeran, SM; Tollefsbol, TO; Yuan, YY | 1 |
| Katiyar, SK; Nandakumar, V; Vaid, M | 1 |
| Fu, HY; Shen, JZ; Shen, SF; Wu, DS; Yu, AF; Zhou, HR | 1 |
4 other study(ies) available for catechin and trichostatin a
| Article | Year |
|---|---|
Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
Topics: Catechin; Cell Survival; Cellular Senescence; Colonic Neoplasms; Drug Synergism; HT29 Cells; Humans; Hydroxamic Acids; Isothiocyanates; Reactive Oxygen Species; Sulfoxides; Superoxide Dismutase; Thiocyanates; Transcription Factor AP-1; Transcriptional Activation | 2008 |
Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; DNA Methylation; Drug Synergism; Estrogen Receptor alpha; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Polymerase Chain Reaction; Promoter Regions, Genetic; Tamoxifen | 2010 |
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Topics: Acetylation; Anticarcinogenic Agents; Azacitidine; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Genes, p16; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Skin Neoplasms; Transcriptional Activation | 2011 |
Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a.
Topics: Catechin; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Lymphoma; Promoter Regions, Genetic | 2013 |